-
THE SOCIETY FOR IMMUNOTHERAPY OF CANCER CONSENSUS STATEMENT ON IMMUNOTHERAPY FOR THE TREATMENT OF NSCLC
Due to the distinct features of cancer immunotherapy, and rapid progress in the field, clinical guidance is needed on the use of these agents, including…
-
IASLC ISSUES STATEMENT PAPER ON LIQUID BIOPSY FOR LUNG CANCER
The lungs can be a difficult organ to biopsy with a needle, so the promise of identifying lung cancer through a blood-based biopsy has lung…
-
ECCO LAUNCHED ACCESS TO INNOVATION PAPER
ECCO and its members have now set out a manifesto for improved access to innovation in a consensus paper published in the European Journal of Cancer.…
-
LUCE AT ASCO 2018 – LUNG CANCER SCREENING
LuCE members Walce Onlus & Fundacion Mas Que Ideas attended the American Society of Clinical Oncology (ASCO) Annual Meeting. They talked with MD Paolo Bironzo about the topics…
-
LUCE AT ASCO 2018 – LUNG CANCER HIGHLIGHTS
Prof. Giulio Scagliotti talked about lungcancer highlights with Stefania Vallone, LuCE president and Diego Villalón, LuCE member. Topics focused on new treatment for scuamous cell carcinoma and…
-
LUCE WEBINAR “HOW TO GET PUBLIC ATTENTION ON A RELEVANT TOPIC”
LuCE latest webinar focused on how your can get higher public influence. Anna Wagstaff, editor of Cancer World (ESO Magazine) shared useful insigts on how…
-
2018 AGM SOFIA
LuCE Board 2018 Between the 20th and the 22nd April, LuCE organized the annual AGM in Sofia. The event being positioned in Sofia supported the…
-
2017 LUCE TRANSLATED REPORT
During latest LuCE Report launching event, Stefania Vallone, LuCE’s President encouraged the attendees to give a step forward, and try working together to get improvement…
-
PRESENTATION: PATIENT PERSPECTIVE ON LUNG CANCER TREATMENT PROGRESS
Stefania, Vallone, LuCE President, was key note speaker @IASLC Lung Cancer Immunotherapy Meeting, held between March 22-25, 2018 in Barcelona. She was presenting patient perspective…